Italia

Menarini Diagnostics acquisisce il ramo d’azienda di EOS e rafforza la sua presenza nel mercato della Preanalitica e Point Of Care.

Firenze, 15 gennaio 2021

A.MENARINI DIAGNOSTICS and BIOACTIVA DIAGNOSTICA GMBH SIGN AN EXCLUSIVE AGREEMENT FOR LIOFERON® TB/LTBI, A TEST TO DIAGNOSE LATENT TUBERCULOSIS INFECTION.

September 3rd, 2020 – Firenze, Italy and Bad Homburg, Germany

ralesci Congresses with "Zero Impact®" on the environmentive drug for chronic hyperuricaemia in gout.D VitaPCR® POC instrument.

On August 20th the German Minister of Health, Jens Spahn visited the Red Cross Hospital of Mölln-Ratzeburg. 

A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

Hsinchu, Taiwan and Florence, Italy, July 24th, 2020

First3456791112

i nostri valori

4 valori, che hanno dato vita a Menarini e ne hanno forgiato la storia. 

LEGGI TUTTO »